Future treatment of hepatitis C: What's around the corner
Publication
, Journal Article
Dev, A; Patel, K; McHutchison, JG
Published in: Infections in Medicine
January 1, 2004
Current therapies for the treatment of chronic hepatitis C are effective in only 50% of patients, are associated with side effects, and are not suited for all patients. Advances in understanding the replication cycle and structural components of the virus have improved the prospects for novel therapies, including strategies to enhance response to current interferon-based therapies; newer nucleoside analogs; inhibitors of virus-specific enzymes; and agents to reduce fibrosis progression. Although these agents represent an exciting phase in the development of effective hepatitis C therapy, several years will be required to establish their safety and efficacy before they can be recommended for routine clinical use.
Duke Scholars
Published In
Infections in Medicine
ISSN
0749-6524
Publication Date
January 1, 2004
Volume
21
Issue
1
Start / End Page
28 / 36
Related Subject Headings
- Microbiology
Citation
APA
Chicago
ICMJE
MLA
NLM
Dev, A., Patel, K., & McHutchison, J. G. (2004). Future treatment of hepatitis C: What's around the corner. Infections in Medicine, 21(1), 28–36.
Dev, A., K. Patel, and J. G. McHutchison. “Future treatment of hepatitis C: What's around the corner.” Infections in Medicine 21, no. 1 (January 1, 2004): 28–36.
Dev A, Patel K, McHutchison JG. Future treatment of hepatitis C: What's around the corner. Infections in Medicine. 2004 Jan 1;21(1):28–36.
Dev, A., et al. “Future treatment of hepatitis C: What's around the corner.” Infections in Medicine, vol. 21, no. 1, Jan. 2004, pp. 28–36.
Dev A, Patel K, McHutchison JG. Future treatment of hepatitis C: What's around the corner. Infections in Medicine. 2004 Jan 1;21(1):28–36.
Published In
Infections in Medicine
ISSN
0749-6524
Publication Date
January 1, 2004
Volume
21
Issue
1
Start / End Page
28 / 36
Related Subject Headings
- Microbiology